Down syndrome critical region 1-like 1 proteins
CA 2415127 A1 · Owner: Loring, Jeanne F. · Inventors: Loring, Jeanne F.; Edwards, Carla M.; Tingley, Debora W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a nucleic acid molecule and fragments thereof. It also provides for the use of the nucleic acid molecule for the characterization diagnosis, evaluation, and treatment of conditions diseases and disorders , associated with gene expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the nucleic acid molecule.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.